Sabirin, Samira D.

HRN: 13-26-81  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/10/2025
CEFUROXIME 750MG (VIAL)
02/10/2025
02/17/2025
IV
500 Mg
Q8H
PCAP-C
Waiting Final Action 
02/10/2025
CEFTRIAXONE 1G (VIAL)
02/10/2025
02/17/2025
IV
1.4 Grams
Q24
PCAP-C
Waiting Final Action 
02/12/2025
CEFTRIAXONE 1G (VIAL)
02/12/2025
02/15/2025
IV DRIP
1.4g
OD
Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: